Portal de Periódicos da CAPES

Rare occurrence of DNMT3A mutations in myelodysplastic syndromes

2011; Ferrata Storti Foundation; Volume: 96; Issue: 12 Linguagem: Inglês

10.3324/haematol.2011.045559

1592-8721

Felicitas Thol, Claudia Winschel, Andrea Lüdeking, Haiyang Yun, Inna Friesen, Frédérik Damm, Katharina Wagner, Juergen Krauter, Michael Heuser, Arnold Ganser,

Myeloproliferative Neoplasms: Diagnosis and Treatment

Gene mutations and epigenetic changes have been shown to play significant roles in the pathogenesis of myelodysplastic syndromes. Recently, mutations in DNMT3A were identified in 22.1% of patients with acute myeloid leukemia. In this study, we analyzed the frequency and clinical impact of DNMT3A mutations in a cohort of 193 patients with myelodysplastic syndromes. Mutations in DNMT3A were found in 2.6% of patients. The majority of mutations were heterozygous missense mutations affecting codon R882. Patients with DNMT3A mutations were found to have a higher rate of transformation to acute myeloid leukemia. When assessing the global methylation levels in patients with mutated versus unmutated DNMT3A and healthy controls no difference in global DNA methylation levels between the two groups was seen. Our data show that in patients with myelodysplastic syndromes, DNMT3A mutations occur at a low frequency and may be a risk factor for leukemia progression.